Equity markets surge as diplomatic talks between Washington and Tehran fuel optimism over reduced Middle East tensions. Global stocks reached record levels after reports emerged of potential negotiations between the US and Iran. Investors reacted positively to signs of de-
Regional equities climb sharply after reports of de-escalation in Middle East conflicts, lifting investor sentiment. Asian stocks surged Monday as easing tensions between Iran and Israel fueled risk appetite, with Japan’s Nikkei 225 index soaring over 5% to a record high.
Investors remain cautious around the 183.75 level amid speculation Japan may step in to stabilize the yen. The EUR/JPY pair traded sideways near 183.75 during Thursday’s Asian session, reflecting investor caution. Market participants are hesitant to take strong positions a
Investors remain cautious as speculation grows over potential Japanese currency intervention to stabilize the yen. The EUR/JPY pair traded sideways around 183.75 in early Asian trading on Thursday, reflecting investor hesitation. Market participants are closely monitoring
The move aims to secure supply for Australia’s east coast amid rising energy demand and price pressures. Australia will require liquefied natural gas exporters to reserve 20% of their production for the domestic east coast market. The policy targets shortages and price vol
Tokyo signals readiness for unlimited currency intervention to stabilize the yen, maintaining close contact with Washington. Japan reiterated it has no restrictions on yen intervention to counter excessive volatility, emphasizing daily coordination with US authorities. The
The explosives maker reported stronger-than-expected profits for the six months to March, prompting a share price rise. Orica posted record first-half earnings, driving a 14% increase in its interim dividend. The company’s net profit rose sharply, outpacing analyst forecas
Bruker expects $3.57-$3.60 billion revenue Bruker has reconfirmed its fiscal year 2026 revenue outlook, expecting $3.57-$3.60 billion. The company also anticipates non-GAAP earnings per share of $2.10-$2.15. A margin expansion of 250-300 bps is being targeted.</p
LifeVantage signals fiscal 2026 results near low end LifeVantage expects fiscal 2026 results to be near the low end of guidance. The company is raising its quarterly dividend by 11% to $0.05. This move indicates a commitment to returning value to shareholders des
The biopharmaceutical firm secures $700 million through a public offering priced at $71 per share. Cytokinetics has priced a $700 million stock offering at $71 per share, bolstering its capital position. The move follows recent advancements in its clinical pipeline, includ
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.